Core Viewpoint - Haocen Medical (002622) has undergone a change in its actual controller due to the termination of a cooperation agreement, resulting in the company becoming a state without an actual controller. This change does not affect the company's normal operations or harm the interests of minority shareholders [1]. Group 1: Stock Performance - As of November 17, 2025, Haocen Medical closed at 3.59 yuan, down 0.83% from the previous trading day, with a total market capitalization of 3.016 billion yuan [1]. - The stock opened at 3.61 yuan, reached a high of 3.64 yuan, and a low of 3.52 yuan, with a trading volume of 90.3627 million yuan and a turnover rate of 3.02% [1]. Group 2: Corporate Announcement - Haocen Medical announced a change in equity and actual controller, stating that the first major shareholder, Huayin Rifeng, has terminated its cooperation agreement with Beijing Shoutuo Ronghui, leading to the change [1]. - The court's effective judgment has confirmed the termination of the cooperation agreement, resulting in Huayin Aofeng controlling the voting rights of 23.81% of the company's shares [1]. - Huayin Aofeng has no actual controller, which means Haocen Medical is now in a state without an actual controller [1].
皓宸医疗(002622)披露关于公司权益变动暨实际控制人变更的公告,11月17日股价下跌0.83%